Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOMYCIN vs MOGAMULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITOMYCIN vs MOGAMULIZUMAB: Safety Overview

Metric MITOMYCIN MOGAMULIZUMAB
Total FAERS Reports 2,111 441
Deaths Reported 231 128
Death Rate 10.9% 29.0%
Hospitalizations 590 181
Average Patient Age 62.8 yrs 64.5 yrs
% Female Patients 48.8% 38.1%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Accord BioPharma Inc. Kyowa Kirin, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A